Page 97 - ASHG 2013 Program Guide

84
INVITED AND PLATFORM SESSIONS
Taking photographs or sound recordings in all meeting rooms is strictly prohibited. Thank you for your cooperation.
Wednesday, October 23
2:00
PM
–4:15
PM
Concurrent Platform (abstract-driven)
Session A (10-18)
SESSION 14 – Cancer Epidemiology: New Loci and
Methods
Room 205, Level 2, Convention Center
Moderators
:
Sharon Savage, NCI/NIH; Antonis C.
Antoniou, Univ. of Cambridge
43
/2:00
Heritability and familial risk of cancer: An
update from the Nordic Twin Registry of Cancer.
L. A. Mucci, J. Kaprio, J. Harris, K. Czene, P. Kraft, T.
Scheike, R. Graff, I. Brandt, N. Holmes, D. Havelick,
M. Hartman, K. Penney, E. Pukkala, G. Parmigiani, A.
Skytthe, H. O. Adami, J. Hjelmborg, Nordic Twin Study
of Cancer (NorTwinCan).
44
/2:15
A comprehensive genetic analysis of
common cancer risk through the development
of the Oncochip.
C. I. Amos, A. C. Antoniou, A.
Berchuck, G. Chenevix-Trench, F. J. Couch, R. A.
Eeles, L. J. Esserman, S. A. Gayther, C. L. Goh, D.
E. Goldgar, S. B. Gruber, C. A. Haiman, P. Hall, D. J.
Hunter, Z. Kote-Jarai, P. K. Lepage, S. Lindstrom, J.
McKay, R. L. Milne, U. Peters, P. D. Pharoah, C. M.
Phelan, F. R. Schumacher, T. A. Sellers, J. Simard, Z.
Wang, D. Seminara, S. J. Chanock, D. F. Easton, B. E.
Henderson.
45
/2:30
Detection of large clonal mosaic events
in existing genome-wide association study data.
M. Machiela, W. Zhou, M. Yeager, K. Jacobs, S.
Berndt, Q. Lan, N. Rothman, S. Savage, P. Taylor,
N. Caporaso, I. DeVivo, R. Hoover, M. Tucker, S.
Chanock.
46
/2:45
Most common ‘sporadic’ cancers have
a substantial germline genetic component.
S.
Macgregor, W. E. Ek, Y. Lu, D. Whiteman, T. L.
Vaughan, A. B. Spurdle, D. F. Easton, P. D. Pharoah,
D. J. Thompson, A. M. Dunning, A. K. Hayward, G.
Chenevix-Trench, Q-MEGA and AMFS Investigators,
ANECS-SEARCH, UKOPS-SEARCH, BEACON
Consortium.
47
/3:00
Meta-analysis of genome-wide association
studies in 125,000 women identifies fourteen new
breast cancer susceptibility loci.
K. Michailidou, P.
Hall, P. Kraft, D. F. Easton, Breast Cancer Association
Consortium, DRIVE.
48/
3:15
Identification of seven new ovarian cancer
susceptibility loci: Risk of ovarian cancer in the
general population and in
BRCA1
and
BRCA2
carriers.
K. Kuchenbaecker, J. Tyrer, F. J. Couch, S.
A. Gayther, P. P. Pharoah, S. J. Ramus, A. C. Antoniou,
G. Chenevix-Trench, CIMBA and OCAC.
49
/3:30
Breast cancer risk and survival at the 2q35
locus are mediated through chromatin looping and
regulation of
IGFBP5
expression.
M. Ghoussaini,
S. L. Edwards, J. D. French, K. Michailidou, S. Nord,
J. Dennis, Q. Guo, M. K. Schmidt, K. Hillman, S.
Kaufmann, E. Dicks, S. Ahmed, M. Maranian, C. S.
Healey, C. Baynes, C. Luccarini, M. Bolla, J. Wang, V.
N. Kristensen, P. D. P. Pharoah, G. Chenevix-Trench, D.
F. Easton, A. M. Dunning, Breast Cancer Association
Consortium.
50
/3:45
Expression quantitative trait loci analysis
in breast cancer tumor and normal adjacent
FFPE specimens from the Nurses’ Health Study.
A. Quiroz-Zarate, B. J. Harshfield, N. Knoblauch, S.
Christe, R. Hu, D. J. Hunter, A. H. Beck, R. M. Tamimi,
J. Quackenbush, A. Hazra, U19/GAME-ON DRIVE
Consortium.
51
/4:00
Finding genes in animal models of
histiocytic sarcoma.
E. A. Ostrander, J. L. Rowell, G.
R. Rutteman, H. G. Parker.